Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 1997

View Archived Issues

Chiroscience discloses cytokine inhibitors

Leukotriene antagonists from Pfizer

Fujisawa reports selective COX-2 inhibitors

Nissan Chem. reveals new antidiabetic agents

Agents with antiinflammatory, immunosuppressive, antiproliferative effects from Roussel Uclaf

Cantab: Q1 1997 highlights

Hayashibara discovers human protein that induces IFN-gamma production

Sagami prepares new anti-H. pylori agents

Coulter: Q1 1997 highlights

New HIV protease inhibitors reported by Kissei

Otsuka reports analgesic agents

Celtrix: Fiscal year-end highlights

Liposomal 5-ASA for IBD: pharmacokinetics in rat jejunum

Promising initial clinical results for mycophenolate in IBD

Favorable clinical results with rifaximin in steroid-resistant ulcerative colitis

Nycomed, SmithKline Beecham refocus hemoregulatory peptide program

Safety and efficacy of oral budesonide (Budenofalk) in Crohn's disease and collagenous colitis

ProCyte launches GraftCyte products

Oral methotrexate for severe IBD in children

Retrospective evaluation of immunosuppressive therapy for pediatric IBD

AltaRex initiates U.S. phase IIb trial with Ovarex

Use of labetalol in renal transplant patients discouraged

Merck & Co. acquires majority share of Gentili

Losartan effective in chronic renal allograft rejection

Promising results with DuPont Merck's DMP-266 reported

FLAP inhibitor from Bayer inhibits allergen-induced bronchoconstriction in atopic asthmatics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...